Primary-progressive MS 进展型多发性硬化 ; 原发进展型
Secondary-progressive MS 进展型多发性硬化 ; 继发 ; 继发进展型
Chronic progressive MS 慢性进展型
secondary progressive MS 继发进展型MS
primary progressive MS 原发进展型MS
progressive-relapsing MS 发型多发性硬化 ; 进展复发型
Therapies are currently available for relapsing-remitting MS, secondary progressive MS and progressive relapsing MS.
目前有针对复发-缓解型,继发-进展型,与进展-复发型多发硬化症的治疗方案。
RNFL loss was most evident in the temporal quadrant, where significant reduction was seen in primary progressive MS versus controls and in secondary versus primary progressive MS.
视网膜神经纤维层的缺失在颞象限最为明显,在原发性进行性多发性硬化与继发性进行性多发性硬化相比时降低显著。
The mean RNFL thickness and macular volume were significantly reduced in secondary progressive MS, but not in primary progressive MS when compared with control RNFL thickness and macular volume.
继发性进展性多发性硬化患者平均视网膜神经纤维层的厚度和黄斑面积值亦降低,但与原发性进展性多发性硬化相比不降低。
应用推荐